Galectin Therapeutics Inc
GALTNasdaqCIK 1133416HealthcareFiscal year ends Dec 31
Reports and events: 419 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1312:00 ET | DEF 14A | Proxy statementPeriod 2026-12-03 | 0001140361-26-039379 |
| 2026-08-1411:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032946 |
| 2026-08-1411:51 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001140361-26-032945 |
| 2026-08-0412:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-031060 |
| 2026-08-0411:50 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-031058 |
| 2026-06-2311:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-026031 |
| 2026-05-1511:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-021496 |
| 2026-05-1511:46 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001140361-26-021495 |
| 2026-03-3111:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-012158 |
| 2026-03-3111:50 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001140361-26-012155 |
| 2026-03-1711:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-009735 |
| 2026-01-2122:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-001866 |
| 2026-01-1222:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-000994 |
| 2025-12-1912:55 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-046115 |
| 2025-12-0813:00 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-044711 |
| 2025-12-0317:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-044148 |
| 2025-11-1412:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-042118 |
| 2025-11-1412:50 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001140361-25-042116 |
| 2025-11-1012:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-041275 |
| 2025-10-2212:00 ET | DEF 14A | Proxy statementPeriod 2025-12-03 | 0001140361-25-038875 |
| 2025-09-0811:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-034242 |
| 2025-08-1411:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-031041 |
| 2025-08-1411:53 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-031039 |
| 2025-07-0911:55 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-025295 |
| 2025-06-1616:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-022574 |
| 2025-05-1511:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-019151 |
| 2025-05-1511:50 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001140361-25-019149 |
| 2025-05-1211:55 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-018277 |
| 2025-03-3111:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-011174 |
| 2025-03-3111:50 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001140361-25-011169 |
| 2025-03-0513:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-007063 |
| 2025-02-1812:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-004971 |
| 2025-01-2813:00 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-002125 |
| 2025-01-2316:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-001687 |
| 2025-01-1313:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000879 |
| 2024-12-2012:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-050005 |
| 2024-12-0313:03 ET | DEF 14A | Proxy statementPeriod 2025-01-23 | 0001140361-24-048239 |
| 2024-11-1413:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-046730 |
| 2024-11-1412:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-046728 |
| 2024-11-1412:51 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001140361-24-046726 |
| 2024-09-0912:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-040509 |
| 2024-08-1311:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036938 |
| 2024-08-1311:50 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001140361-24-036937 |
| 2024-08-0111:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-035212 |
| 2024-05-1511:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-026106 |
| 2024-05-1511:50 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001140361-24-026105 |
| 2024-03-2911:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-016454 |
| 2024-03-2911:51 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001140361-24-016452 |
| 2023-12-1121:15 ET | 8-K | 5.07 Shareholder vote results | 0001140361-23-057155 |
| 2023-12-0716:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-056586 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.